GlassScriptPhysician profile
Kristen E Holtz
NPI 1568959096
$1,957.95
in general payments reported to CMS, 2019-2025
14 companies · $35.00 in 2025
The $35.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.20 · 2021: $12.18 · 2022: $138 · 2023: $261 · 2024: $1,483 · 2025: $35.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,127 · Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,126.86 |
| Food and Beverage | $652.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,510.73 | 2023-2024 | Farxiga |
| Amgen INC. | $142.64 | 2022-2023 | Otezla, Repatha |
| Novo Nordisk INC | $59.99 | 2021-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $58.50 | 2023 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $47.39 | 2020-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $35.00 | 2025 | |
| Abbvie INC. | $19.21 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.91 | 2023 | |
| Exact Sciences Corporation | $17.49 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $17.25 | 2023 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 2023 | Camzyos |
| Shield Therapeutics INC | $14.82 | 2023 | Accrufer |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Holtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.